Previous studies have recognized that the elevation of palmitate in the context of obesity may induce NLRP3 inflammasome activation in macrophages, leading to the overproduction of inflammatory cytokines and subsequent insulin resistance in mice (125, 126). Here, NLRP3 is linked to obesity disorder.